Indication · Cardiology
Heart failure
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
604
Cleared or approved since 2000
PMA and De Novo
464
Higher-risk or first-of-kind devices
Breakthrough devices
14
Authorized through June 30, 2026
Recruiting device trials
218
1,715 device trials in all
Breakthrough-designated devices
- EchoNextPathwai, Inc. · 2026
13 more devices with a free account
Devices
5 devices via De Novo. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Triage B-Type Natriuretic Peptide (Bnp) Test
Biosite Incorporated · De Novo · Test, Natriuretic Peptide · newest 2002 · 3 decisions
4 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label DevicesNot yet recruiting
National Heart, Lung, and Blood Institute (NHLBI)NIH
NCT07806149 · 200 participants (planned) · Start Nov 25, 2026 · Primary completion Mar 1, 2029
Device: SESAME Procedure · For: Hypertrophic Cardiomyopathy; Left Ventricular Outflow Obstruction; Systolic Anterior Motion
Sites: Washington D.C., District of Columbia; Atlanta, Georgia; Boston, Massachusetts · 8 sites in all
1,714 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK)153
- Pulse Generator, Permanent, Implantable (NVZ)148
- Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P) (NKE)59
- Plethysmograph, Impedance (DSB)42
- Ventricular (Assist) Bypass (DSQ)33
- Test, Natriuretic Peptide (NBC)32
- Device, Counter-Pulsating, External (DRN)21
- Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode (OJX)17
- Catheter, Flow Directed (DYG)15
- Programmer, Pacemaker (KRG)10
- Enzyme Immunoassay, Digoxin (KXT)10
- Pacemaker/Icd/Crt Non-Implanted Components (OSR)10
- System, Hemodynamic, Implantable (MOM)7
- Artificial Heart (LOZ)6
- Reduced Ejection Fraction Machine Learning-Based Notification Software (QYE)6
- Temporary Non-Roller Type Right Heart Support Blood Pump (PYX)5
- Catheter, Hemodialysis, Non-Implanted, Ultrafiltration, For Peripheral Use (NQJ)3
- Implantable Pulse Generator (QFV)3
- Adjunctive Heart Failure Status Indicator (QUO)3
- Pulmonary Hypertension Machine Learning-Based Notification Software (SAT)3
- Adjunctive Cardiac Amyloidosis Status Indicator (SDJ)3
- Stimulator, Carotid Sinus Nerve (DSR)2
- Enzyme Immunoassay, Digitoxin (LFM)2
- Cardiac Allograft Gene Expression Profiling Test System (OJQ)2
- Organ Care System (Ocs) Heart System (QIK)2
- Cardiovascular Machine Learning-Based Notification Software (QXO)2
- St2 Assay (OYG)1
- Radiological Machine Learning Based Quantitative Imaging Software With Change Control Plan (QVD)1
- Leadless Cardiac Resynchronization Therapy (Crt) (SEG)1
- Cardiac Amyloidosis Machine Learning-Based Notification Software (SHP)1
Research
- Device studies on heart failure across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.